Clinical Trial Update: Temozolomide as Maintenance Therapy in Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating temozolomide as maintenance therapy in small cell lung cancer; the update provides no results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Carcinoma, Small Cell | Phase 2 | Status: UNKNOWN